Let’s innovate together to advance global health

Search Medical and Clinical Information

Search for Clinical Trials

Recruiting Status
Not yet recruiting | Recruiting | Active, no longer recruiting | Completed

Recruiting Status

Expand Filter
Trial ID
Condition

Study Type

• Interventional trials
• Observational trials
• Patient registries
• Expanded access trials

Study Results

Both | Trials with results | Trials without results

Accepts Healthy Patients

Both | Yes | No

Gender

Any | Male | Female

Age

Any | Child (0-17) | Adult (18-65) | Senior (65+)

Study Phase

• Early Phase 1
• Phase 1
• Phase 2
• Phase 3
• Phase 4
• Not specified

Travel Distance

Any distance | 0-50 miles | 0-100 miles | 0-150 miles

Search Medical Response Documents for FDA-approved BI products available in the US.

Product

• Aptivus® (tipranavir) Capsules
• Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol
• Combivent® Respimat® (ipratropium bromide and albuterol inhalation spray)
• Cyltezo® (adalimumab-abdm) injection
• Gilotrif® (afatinib) tablets
• Glyxambi® (empagliflozin and linagliptin) Tablets
• Hernexeos® (zongertinib) Tablets
• Jardiance® (empagliflozin) Tablets
• Jascayd® (nerandomilast) Tablets
• Jentadueto® Tablets (linagliptin and metformin)
• Jentadueto® XR extended-release tablets (linagliptin and metformin)
• Micardis® HCT Tablets (telmisartan and hydrochlorothiazide)
• Micardis® Tablets (telmisartan)
• Mirapex ER® extended-release tablets (pramipexole dihydrochloride extended release)
• Ofev® (nintedanib capsules)
• Pradaxa® (dabigatran etexilate) ORAL PELLETS
• Pradaxa® (dabigatran etexilate) capsules
• Praxbind® (idarucizumab) injection
• Spiriva® HANDIHALER® (tiotropium bromide) inhalation powder
• Spiriva® Respimat® (tiotropium bromide inhalation spray)
• Stiolto® Respimat® (tiotropium bromide and olodaterol inhalation spray)
• Striverdi® Respimat® (olodaterol)
• Synjardy® Tablets (empagliflozin and metformin hydrochloride)
• Synjardy® XR extended-release Tablets (empagliflozin and metformin hydrochloride extended release)
• Tradjenta® (linagliptin) tablets
• Trijardy® XR Tablets (empagliflozin, linagliptin, and metformin hydrochloride extended-release)

Search by Therapeutic Area or Congress

All Therapeutic Areas

• Cardiovascular-Renal-Metabolic
• Mental Disorders
• Oncology
• Respiratory
• Eye Health

Year

• 2026
• 2025

Your comprehensive online resource to access medical  information and improve patient care

Diseases & Conditions

We're pleased to provide healthcare professionals (HCPs) with robust educational materials and resources across various indications and therapeutic areas, such as Cardiovascular, Renal, Metabolic, Oncology, Respiratory, and Eye and Mental health conditions.

Clinical Trials

Explore BI clinical trials and join a thriving community of clinical research investigators who are committed to improving awareness and reaching more potential clinical participants.

Scientific Congresses

Discover the latest developments in your field of expertise by staying updated on upcoming congresses and browsing through materials from past medical and scientific meetings.

Report an Adverse Event

To report an adverse event to Boehringer Ingelheim, please call
1-800-542-6257

Submit Questions Electronically

To submit a medical information request or other medical inquiries to BI electronically, please visit
https://www.bi-druginforequest.com

Contact Us by Phone

For information about a BI product, please call
1-800-542-6257

Connect With My MSL

Find an MSL in your area to get answers to your questions about BI products and up-to-date clinical information.